Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Circ Res ; 100(9): 1317-27, 2007 May 11.
Article in English | MEDLINE | ID: mdl-17413045

ABSTRACT

Phosphorylation of ion channels plays an important role in the regulation of cardiac function, but signaling mechanisms controlling dephosphorylation are not well understood. We have tested the hypothesis that p(21)-activated kinase-1 (Pak1), a serine-threonine protein kinase regulated by Ras-related small G proteins, regulates sinoatrial node (SAN) ion channel activity through a mechanism involving protein phosphatase 2A. We report a novel role of Pak1-mediated signaling in attenuating isoproterenol-induced enhancement of L-type Ca(2+) current (I(CaL)) and delayed rectifier potassium current (I(K)) in guinea pig SAN pacemaker cells. We demonstrate that in guinea pig SAN: (1) there is abundant expression of endogenous Pak1 in pacemaker cells; (2) expression of constitutively active Pak1 depresses isoproterenol-induced upregulation of I(CaL) and I(K); (3) inhibition of protein phosphatase 2A increases the enhancement of I(K) and I(CaL) by isoproterenol in Ad-Pak1-infected cells; (4) protein phosphatase 2A coimmunoprecipitates with endogenous Pak1 in SAN tissue; and (5) expression of constitutively active Pak1 suppresses the chronotropic action of isoproterenol on pacemaker activity of intact SAN preparations. In conclusion, our data demonstrate that a Pak1 signaling pathway exists in cardiac pacemaker cells and that this novel pathway plays a role in the regulation of ion channel activity.


Subject(s)
Calcium Channels, L-Type/physiology , Delayed Rectifier Potassium Channels/physiology , Protein Serine-Threonine Kinases/physiology , Sinoatrial Node/metabolism , Animals , Female , Guinea Pigs , Heart Rate/drug effects , Isoproterenol/pharmacology , Phosphoprotein Phosphatases/physiology , Protein Phosphatase 2 , Transfection , p21-Activated Kinases
2.
J Biol Chem ; 282(20): 15302-11, 2007 May 18.
Article in English | MEDLINE | ID: mdl-17387177

ABSTRACT

In cardiac muscle the sarcoplasmic reticulum (SR) plays a key role in the control of contraction, releasing Ca(2+) in response to Ca(2+) influx across the sarcolemma via voltage-gated Ca(2+) channels. Here we report evidence for an additional distinct Ca(2+) store and for actions of nicotinic acid adenine dinucleotide phosphate (NAADP) to mobilize Ca(2+) from this store, leading in turn to enhanced Ca(2+) loading of the SR. Photoreleased NAADP increased Ca(2+) transients accompanying stimulated action potentials in ventricular myocytes. The effects were prevented by bafilomycin A (an H(+)-ATPase inhibitor acting on acidic Ca(2+) stores), by desensitizing concentrations of NAADP, and by ryanodine and thapsigargin to suppress SR function. Bafilomycin A also suppressed staining of acidic stores with Lysotracker Red without affecting SR integrity. Cytosolic application of NAADP by means of its membrane permeant acetoxymethyl ester increased myocyte contraction and the frequency and amplitude of Ca(2+) sparks, and these effects were inhibited by bafilomycin A. Effects of NAADP were associated with an increase in SR Ca(2+) load and appeared to be regulated by beta-adrenoreceptor stimulation. The observations are consistent with a novel role for NAADP in cardiac muscle mediated by Ca(2+) release from bafilomycin-sensitive acidic stores, which in turn enhances SR Ca(2+) release by increasing SR Ca(2+) load.


Subject(s)
Action Potentials/drug effects , Calcium/metabolism , Ion Channel Gating/drug effects , Myocytes, Cardiac/metabolism , NADP/analogs & derivatives , Sarcolemma/metabolism , Animals , Calcium Channels/metabolism , Enzyme Inhibitors/pharmacology , Guinea Pigs , Heart Ventricles/cytology , Heart Ventricles/metabolism , Macrolides/pharmacology , Myocytes, Cardiac/cytology , NADP/metabolism , NADP/pharmacology , Proton-Translocating ATPases/antagonists & inhibitors , Proton-Translocating ATPases/metabolism , Receptors, Adrenergic, beta/metabolism , Ryanodine/pharmacology , Thapsigargin/pharmacology
3.
Cell Calcium ; 41(6): 537-46, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17156839

ABSTRACT

The actions of cyclic ADP-ribose (cADPR), a regulator of Ca2+-induced Ca2+ release (CICR), were investigated on Ca2+ release and sarcoplasmic reticulum (SR) Ca2+ loading in cardiac myocytes at physiological temperature. In guinea-pig ventricular cells, cADPR, applied via patch pipette or from photorelease of its caged derivative, increased contraction amplitude and whole-cell Ca2+ transients, without affecting SR Ca2+ load (measured in response to rapid caffeine application). Under voltage-clamp conditions, photorelease of caged cADPR enhanced Ca2+ transient magnitude without affecting the peak amplitude of L-type Ca2+ current or its rate of decay, indicative of an increase in CICR gain. In rat permeabilised ventricular myocytes, rapid application of cADPR increased Ca2+ spark frequency within 30 s, and this effect was maintained over a 10 min exposure. Enhancement of spark frequency was not associated with changes in SR Ca2+ load at 30 s and 3 min of exposure to cADPR; however, prolonged exposure (10 min) was associated with an increased SR Ca2+ load (32+/-7%). The observations are consistent with dual actions of cADPR: a rapid effect on CICR that does not depend on an increased SR Ca2+ load, and an additional slower effect that is associated with enhanced SR Ca2+ levels.


Subject(s)
Calcium Signaling , Calcium/metabolism , Cyclic ADP-Ribose/analogs & derivatives , Myocytes, Cardiac/metabolism , Animals , Cyclic ADP-Ribose/pharmacology , Guinea Pigs , In Vitro Techniques , Microscopy, Confocal , Myocytes, Cardiac/drug effects , Patch-Clamp Techniques , Rats , Sarcoplasmic Reticulum/drug effects , Sarcoplasmic Reticulum/metabolism
4.
J Physiol ; 571(Pt 3): 639-49, 2006 Mar 15.
Article in English | MEDLINE | ID: mdl-16423859

ABSTRACT

Na+-Ca2+ exchange (NCX) current has been suggested to play a role in cardiac pacemaking, particularly in association with Ca2+ release from the sarcoplasmic reticulum (SR) that occurs just before the action potential upstroke. The present experiments explore in more detail the contribution of NCX to pacemaking. Na+-Ca2+ exchange current was inhibited by rapid switch to low-Na+ solution (with Li+ replacing Na+) within the time course of a single cardiac cycle to avoid slow secondary effects. Rapid switch to low-Na+ solution caused immediate cessation of spontaneous action potentials. ZD7288 (3 microM), to block I(f) (funny current) channels, slowed but did not stop the spontaneous activity, and tetrodotoxin (10 microM), to block Na+ channels, had little effect, but in the presence of either of these agents, rapid switch to low-Na+ solution again caused immediate cessation of spontaneous action potentials. Spontaneous electrical activity was also stopped following loading of the cells with the Ca2+ chelators BAPTA and EGTA, and by exposure to the NCX inhibitor KB-R7943 (5 microM). When rapid switch to low-Na+ solution caused cessation of spontaneous activity, this was found (using confocal microscopy, with fluo-4 as the Ca2+ probe) to be accompanied by an initial fall in cytosolic [Ca2+], with subsequent appearance of Ca2+ waves. Inhibition of SR Ca2+ uptake with cyclopiazonic acid (CPA, 30 microM) slowed but did not stop spontaneous activity. Rapid switch to low-Na+ solution in the presence of CPA caused abolition of spontaneous Ca2+ transients and a progressive rise in cytosolic [Ca2+]. With ratiometric fluorescence methods (indo-5F as the Ca2+ probe), the minimum level of [Ca2+] between beats was found to be approximately 225 nM, and abolition of beating with nifedipine, acetylcholine or adenosine caused a fall in cytosolic [Ca2+] below this level. These observations support the hypothesis that NCX current is essential for normal pacemaker activity under the conditions of our experiments. A continuous depolarizing influence of current through the NCX protein might result from maintained electrogenic NCX (with 3:1 stoichiometry, supported by a cytosolic [Ca2+] that normally does not fall below 225 nM between beats) and/or from a novel, recently suggested role of the NCX protein to allow a Na+ leak pathway.


Subject(s)
Calcium/metabolism , Chelating Agents/pharmacology , Egtazic Acid/analogs & derivatives , Sinoatrial Node/metabolism , Sodium-Calcium Exchanger/metabolism , Sodium/metabolism , Action Potentials , Animals , Anti-Arrhythmia Agents/pharmacology , Egtazic Acid/pharmacology , Guinea Pigs , In Vitro Techniques , Indoles/pharmacology , Male , Pyrimidines/pharmacology , Sarcoplasmic Reticulum/drug effects , Sarcoplasmic Reticulum/metabolism , Sinoatrial Node/drug effects , Sodium Channel Blockers/pharmacology , Sodium-Calcium Exchanger/antagonists & inhibitors , Tetrodotoxin/pharmacology , Thiourea/analogs & derivatives , Thiourea/pharmacology
5.
Circ Res ; 92(5): e52-9, 2003 Mar 21.
Article in English | MEDLINE | ID: mdl-12623875

ABSTRACT

A neuronal isoform of nitric oxide synthase (nNOS) has recently been located to the cardiac sarcoplasmic reticulum (SR). Subcellular localization of a constitutive NOS in the proximity of an activating source of Ca2+ suggests that cardiac nNOS-derived NO may regulate contraction by exerting a highly specific and localized action on ion channels/transporters involved in Ca2+ cycling. To test this hypothesis, we have investigated myocardial Ca2+ handling and contractility in nNOS knockout mice (nNOS-/-) and in control mice (C) after acute nNOS inhibition with 100 micromol/L L-VNIO. nNOS gene disruption or L-VNIO increased basal contraction both in left ventricular (LV) myocytes (steady-state cell shortening 10.3+/-0.6% in nNOS-/- versus 8.1+/-0.5% in C; P<0.05) and in vivo (LV ejection fraction 53.5+/-2.7 in nNOS-/- versus 44.9+/-1.5% in C; P<0.05). nNOS disruption increased ICa density (in pA/pF, at 0 mV, -11.4+/-0.5 in nNOS-/- versus -9.1+/-0.5 in C; P<0.05) and prolonged the slow time constant of inactivation of ICa by 38% (P<0.05), leading to an increased Ca2+ influx and a greater SR load in nNOS-/- myocytes (in pC/pF, 0.78+/-0.04 in nNOS-/- versus 0.64+/-0.03 in C; P<0.05). Consistent with these data, [Ca2+]i transient (indo-1) peak amplitude was greater in nNOS-/- myocytes (410/495 ratio 0.34+/-0.01 in nNOS-/- versus 0.31+/-0.01 in C; P<0.05). These findings have uncovered a novel mechanism by which intracellular Ca2+ is regulated in LV myocytes and indicate that nNOS is an important determinant of basal contractility in the mammalian myocardium. The full text of this article is available at http://www.circresaha.org.


Subject(s)
Calcium/metabolism , Myocardial Contraction , Myocytes, Cardiac/enzymology , Myocytes, Cardiac/physiology , Nitric Oxide Synthase/physiology , Ornithine/analogs & derivatives , Animals , Calcium/analysis , Calcium Channels/physiology , Electric Conductivity , Enzyme Inhibitors/pharmacology , Heart Ventricles/cytology , Heart Ventricles/enzymology , Mice , Mice, Knockout , Myocardium/enzymology , Myocardium/metabolism , Myocytes, Cardiac/cytology , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide Synthase/genetics , Nitric Oxide Synthase Type I , Ornithine/pharmacology , Patch-Clamp Techniques , Sarcoplasmic Reticulum/chemistry , Sarcoplasmic Reticulum/enzymology , Ventricular Function
SELECTION OF CITATIONS
SEARCH DETAIL
...